enfortumab vedotin
seagen,astellas
['vedo', ' vedo', 'urothelial', 'enfortumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'blcsm', 'biomarker']
potential biomarkers of response identified for enfortumab vedotin in advanced urothelial cancer #gu23 #blcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.